Cargando…
The novel cyclophilin inhibitor C105SR reduces hepatic ischaemia–reperfusion injury via mitoprotection
BACKGROUND & AIMS: Mitochondrial permeability transition pore (mPTP) opening is critical for mediating cell death during hepatic ischaemia–reperfusion injury (IRI). Blocking mPTP opening by inhibiting cyclophilin D (CypD) is a promising pharmacological approach for the treatment of IRI. Here, we...
Autores principales: | Kheyar, Amel, Ahnou, Nazim, Ahmed-Belkacem, Abdelhakim, Hulin, Anne, Pressiat, Claire, Ghaleh, Bijan, Guichou, Jean-François, Morin, Didier, Pawlotsky, Jean-Michel, Teixeira-Clerc, Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582583/ https://www.ncbi.nlm.nih.gov/pubmed/37860051 http://dx.doi.org/10.1016/j.jhepr.2023.100876 |
Ejemplares similares
-
Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities
por: Ahmed-Belkacem, Abdelhakim, et al.
Publicado: (2016) -
Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention
por: Ahmed-Belkacem, Abdelhakim, et al.
Publicado: (2014) -
Inhibition of SARS-CoV-2 Infection by the Cyclophilin Inhibitor Alisporivir (Debio 025)
por: Softic, Laurent, et al.
Publicado: (2020) -
Characterization of the Anti-Hepatitis C Virus Activity of New Nonpeptidic Small-Molecule Cyclophilin Inhibitors with the Potential for Broad Anti-Flaviviridae Activity
por: Nevers, Quentin, et al.
Publicado: (2018) -
Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity
por: Van Bael, Jens, et al.
Publicado: (2023)